Literature DB >> 32409919

Characterization of Huh7 cells after the induction of insulin resistance and post-treatment with metformin.

José Manuel Villalva-Pérez1, Marco Antonio Ramírez-Vargas2, Jesús Isimar Serafín-Fabían1, Mónica Ramírez3, Ma Elena Moreno-Godínez2, Mónica Espinoza-Rojo4, Eugenia Flores-Alfaro5.   

Abstract

Liver-specific insulin resistance is associated with the development of the main challenges in metabolism, resulting in dyslipidemia, hyperinsulinemia and hyperglycemia. In vitro models developed for researching hepatic insulin resistance are limited and employed cell lines without similar characteristics to primary human hepatocytes. The Huh7 cell line has been established as a model with similar characteristics to primary human hepatocytes. In addition, it has been identified in the Huh7 cell line that infection with the hepatitis C virus induces insulin resistance. Therefore, we analyzed the induction of insulin resistance (IR) in the Huh7 cell line using an overdosage of insulin and treatment with metformin for its reversal, with the purpose of establishing an insulin resistance model useful for metabolic and pharmacological studies. Insulin-resistant Huh7 (Huh7-IR) showed a reduction in Glut2, glycogen levels, and glucose uptake stimulated by insulin or tyrosine phosphorylation from the β-fraction of insulin receptor post-insulin stimulation, with an increase of glucose production and lipid intracellular content. These biomarkers are frequently observed in insulin-resistant hepatic cells. Moreover, treatment of Huh7-IR with 0.5, 1 or 2 mM of metformin by 24 h decreased the biomarkers associated with an insulin-resistant state. These results suggest that Huh7-IR could be used as an in vitro system to research hepatic insulin resistance in metabolic and pharmacological studies.

Entities:  

Keywords:  Huh7 cells; Insulin resistance; Insulin resistance biomarkers; Metformin

Year:  2020        PMID: 32409919      PMCID: PMC7450031          DOI: 10.1007/s10616-020-00398-4

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  34 in total

1.  Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2.

Authors:  Jenny E Gunton; Patric J D Delhanty; Shin-Ichiro Takahashi; Robert C Baxter
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

2.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

3.  Insulin resistance as a predictor of age-related diseases.

Authors:  F S Facchini; N Hua; F Abbasi; G M Reaven
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

4.  Ferulic acid regulates hepatic GLUT2 gene expression in high fat and fructose-induced type-2 diabetic adult male rat.

Authors:  Akilavalli Narasimhan; Mayilvanan Chinnaiyan; Balasubramanian Karundevi
Journal:  Eur J Pharmacol       Date:  2015-05-05       Impact factor: 4.432

5.  Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells.

Authors:  S Choi; B Sainz; P Corcoran; S Uprichard; H Jeong
Journal:  Xenobiotica       Date:  2009-03       Impact factor: 1.908

6.  Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes.

Authors:  J M Lord; S I White; C J Bailey; T W Atkins; R F Fletcher; K G Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12

7.  Hepatitis C virus E2 protein involve in insulin resistance through an impairment of Akt/PKB and GSK3β signaling in hepatocytes.

Authors:  Ming-Ju Hsieh; Kuang-Ping Lan; Hao-Yu Liu; Xiao-Zong Zhang; Yaw-Feng Lin; Tzy-Yen Chen; Hui-Ling Chiou
Journal:  BMC Gastroenterol       Date:  2012-06-21       Impact factor: 3.067

8.  Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virus.

Authors:  Jingkun Liu; Linbang Wang; Wenjun Wang; Yaping Li; Xiaoli Jia; Song Zhai; Juan Shi; Shuangsuo Dang
Journal:  Mol Med Rep       Date:  2016-07-18       Impact factor: 2.952

9.  In vitro cellular models of human hepatic fatty acid metabolism: differences between Huh7 and HepG2 cell lines in human and fetal bovine culturing serum.

Authors:  Pippa J Gunn; Charlotte J Green; Camilla Pramfalk; Leanne Hodson
Journal:  Physiol Rep       Date:  2017-12

10.  Effects of metformin on the PI3K/AKT/FOXO1 pathway in anaplastic thyroid Cancer cell lines.

Authors:  Zahra Nozhat; Samira Mohammadi-Yeganeh; Feridoun Azizi; Maryam Zarkesh; Mehdi Hedayati
Journal:  Daru       Date:  2018-09-21       Impact factor: 3.117

View more
  3 in total

1.  Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells.

Authors:  Domenica Scordamaglia; Francesca Cirillo; Marianna Talia; Maria Francesca Santolla; Damiano Cosimo Rigiracciolo; Lucia Muglia; Azzurra Zicarelli; Salvatore De Rosis; Francesca Giordano; Anna Maria Miglietta; Ernestina Marianna De Francesco; Veronica Vella; Antonino Belfiore; Rosamaria Lappano; Marcello Maggiolini
Journal:  J Transl Med       Date:  2022-06-07       Impact factor: 8.440

2.  Metformin improves high-fat diet-induced insulin resistance in mice by downregulating the expression of long noncoding RNA NONMMUT031874.2.

Authors:  Zhi-Mei Zhang; Zhi-Hong Liu; Qian Nie; Xue-Mei Zhang; Li-Qun Yang; Chao Wang; Lin-Lin Yang; Guang-Yao Song
Journal:  Exp Ther Med       Date:  2022-03-16       Impact factor: 2.447

Review 3.  Role of Long Non-Coding RNAs and the Molecular Mechanisms Involved in Insulin Resistance.

Authors:  Vianet Argelia Tello-Flores; Fredy Omar Beltrán-Anaya; Marco Antonio Ramírez-Vargas; Brenda Ely Esteban-Casales; Napoleón Navarro-Tito; Luz Del Carmen Alarcón-Romero; Carlos Aldair Luciano-Villa; Mónica Ramírez; Óscar Del Moral-Hernández; Eugenia Flores-Alfaro
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.